This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenfield, R. A.
Right arrow Articles by Craig, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenfield, R. A.
Right arrow Articles by Craig, W. A.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1982 May; 21(5): 846-847
Copyright © 1982, American Society for Microbiology. All Rights Reserved.

In Vitro Susceptibility of Clostridium difficile Isolates to Cefotaxime, Moxalactam, and Cefoperazone

Ronald A. Greenfield1, Terrence A. Kurzynski2 and William A. Craig1

1 Departments of Medicine, William S. Middleton Memorial Veterans Hospital and University of Wisconsin School of Medicine, Madison, Wisconsin 53705,
2 Wisconsin State Laboratory of Hygiene, Madison, Wisconsin 53706

ABSTRACT

The in vitro susceptibility of 20 isolates of Clostridium difficile to cefotaxime, moxalactam, and cefoperazone was determined by a standard agar dilution method. The median minimal inhibitory concentrations were 64, 32, and 32 µg/ml for cefotaxime, moxalactam, and cefoperazone, respectively.

Antimicrob Agents Chemother. 1982 May; 21(5): 846-847
Copyright © 1982, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»